Radioimmunodetection and therapy of breast cancer
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 35 (2) , 143-151
- https://doi.org/10.1053/j.semnuclmed.2004.12.001
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applicationsProtein Engineering, Design and Selection, 2004
- Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 MucinTumor Biology, 1998
- Antibody imaging in breast cancerSeminars in Nuclear Medicine, 1997
- 186Re-Labeled Antibodies to p185HER2as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with125I and131I-Labeled CounterpartsCancer Biotherapy & Radiopharmaceuticals, 1996
- Breast Cancer99mTc Sm3 RadioimmunoscintigraphyActa Oncologica, 1996
- New developments in monoclonal antibodies for cancer detection and therapyCA: A Cancer Journal for Clinicians, 1994
- MAb 170H.82Nuclear Medicine Communications, 1992
- A phase‐i study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin a to suppress the immune responseInternational Journal of Cancer, 1991
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982